Home > HP (current issue) > Meetings | Search

PJ Online homeHospital Pharmacist
2006;13:161-166
May 2006

Hospital Pharmacist back issues

Special features

Inflammatory bowel disease — drug treatment and its implications

By Anja St Clair Jones, MRPharmS

This article as a FULL TEXT PDF (70K)


Anja St Clair Jones is surgical directorate pharmacist at Brighton and Sussex Universities Hospitals NHS Trust

GJLP / SPL

Intestinal inflammation

Reducing intestinal inflammation is the aim of most of the drug treatments for inflammatory bowel diseases

ABSTRACT

Most of the currently available drug treatments for inflammatory bowel diseases aim to reduce the inflammation in the intestine. The second part of this month's special feature gives information about the preparations used, including details about drug delivery

Back to Top


©The Pharmaceutical Journal